Decreased substrate affinity upon alteration of the substrate-docking region in cytochrome P450BM-3  by Maves, Shelley A. et al.
FEBS 19147 FEBS Letters 414 (1997) 213 218 
Decreased substrate affinity upon alteration of the substrate-docking 
region in cytochrome P450BM_3 
Shelley A. Maves, Hyeyeong Yeom 1, Mark A. McLean, Stephen G. Sligar* 
Beckman lnstitute fi)r Advanced Science and Technology and Department of Biochemistry. University ~?f lll#lois. 405 N. Mathews Avenue. 
Urhana, 1L 61801, USA 
Received 19 June 1997; revised version received 28 July 1997 
Abstract A mutation at the surface of the substrate access 
channel which dramatically decreases the affinity for some fatty 
acids in P450BM-3 was discovered by random mutagenesis. The 
mutation introduced, proline-25 to glutamine, is in close 
proximity to the arginine-47 residue thought to be responsible 
for the initial docking of fatty acid substrates. The P25Q mutant 
displays an affinity for palmitate which is approximately 100- 
fold weaker than the wild-type enzyme. In addition to its altered 
substrate affinity, P25Q also exhibits altered hydroxylation 
specificity and carbon monoxide recombination kinetics in the 
substrate-free form. 
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1. Introduction 
Cytochrome P450BM 3 is a heme-containing monooxyge- 
nase isolated from Bacillus megaterium and is one of only 
two known P450s that are catalytically self-sufficient [1,2]. 
They consist of a single polypeptide containing both a cata- 
lytic heme domain and a FAD/FMN reductase domain which 
utilizes NADPH as an electron donor. P450BM-3 catalyzes the 
~-n (n-- 1-3) hydroxylation of fatty acids of varying chain 
lengths [3]. The proposed mechanism for this reaction begins 
with substrate binding and proceeds through a number of 
intermediates which result in oxidation of the substrate and 
regeneration of the resting state of P450. In P450cam, where 
much of the cytochrome P450 mechanism has been elucidated 
[4], the initial binding of substrate in the active-site pocket 
replaces a water molecule ligated to the heme and results in 
a change from a low-spin six-coordinated iron to a high-spin 
five-coordinated iron [5-7]. A similar reaction cycle is thought 
to be operational in P450BM a. 
The crystal structure of P450 ..... shows a largely hydropho- 
bic heme pocket with no clear access channel for the substrate 
[8]. In comparison, the active site of P450BM_3 appears very 
different, with the presence of a long predominately hydro- 
phobic channel providing a clear path for the substrate to the 
heme [9]. Another interesting difference between the two ac- 
tive sites is the observation that P450BM-3 appears to undergo 
a large-scale conformational change following substrate bind- 
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ing. While this conformation change is not yet fully under- 
stood, recent work including dynamic simulations [10], solu- 
tion of the substrate-bound crystal structure [11] and carbon 
monoxide (CO) recombination kinetics [12] demonstrate a 
large difference between the substrate-bound and substrate- 
free forms, suggesting a closing or occlusion of the active 
site upon binding. In addition, the substrate-bound crystal 
structure shows that the substrate initially binds at a distance 
of approximately 7 ]k from the iron. NMR paramagnetic 
relaxation studies suggest hat the substrate then undergoes 
physical displacement upon reduction of the enzyme, bringing 
the substrate closer to the iron [13]. 
The initial docking of fatty acid substrates i  thought o be 
mediated by the formation of hydrogen bonds or ion pairs 
between the carboxylic acid group of the substrate and resi- 
dues Arg 4r and Tyr '51 [11,14]. Replacement of R47 with a 
negatively charged residue inhibited catalysis completely, 
while mutation to an alanine allowed for substrate turnover, 
but led to a decreased affinity for substrate and an altered 
product distribution [14]. These results suggested that R47 is 
responsible for the initial tight binding and subsequent orien- 
tation of the substrate in the active site. 
Several other studies utilized site-directed mutagenesis to
elucidate interactions important for molecular ecognition in 
P450BM :~ [15 18]. While these studies have greatly contrib- 
uted to our current understanding of substrate binding, there 
are limitations of how much information one can obtain in a 
given time period using these methods, lnstead, another ap- 
proach to the problem is to first seek an interesting substrate- 
binding phenotype, and then determine the molecular basis 
for the change in specificity, which can be accomplished by 
generating a large library of mutants via r ndom mutagenesis. 
One advantage of this method is the ability to discover muta- 
tions perturbing important interactions which may not have 
otherwise been predicted. 
In this communication, the results from random mutagen- 
esis of P450BM 3 will be discussed. As a result of this work the 
mutation P25Q, which is located in the substrate access chan- 
nel, was found to greatly reduce the binding affinity of palmi- 
tate to the enzyme. This mutation is not located in any of the 
proposed substrate recognition regions [19], and therefore 
would probably not have been otherwise predicted to affect 
substrate binding. Hence, random mutagenesis methods can 
uncover important structural features in cytochrome P450 
that determine substrate specificity, even those that are distant 
from the heme active center and/or may not be obvious from 
the static crystal structure. 
2. Material and methods 
The library of random P4501~xl :~ mutants was generated by trans- 
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Fig. 1. Geminate CO rebinding transients for wild-type P450BM 3 and random mutants 44, 74, and 82. The traces were measured using lysate 
solutions of the protein to give ODs of 0.01. 300 averages were taken of each sample and all were normalized to the maximum absorbance 
change. 
forming the pUCl3bm3 [20] plasmid containing the P450 gene into an 
E. coli mutator strain, XLI-Red® from Stratagene. This mutator 
strain is deficient in its ability to repair mismatches through the 3' 
to 5' exonuclease activity of DNA polymerase III, and its ability to 
hydrolyze 8-oxodGTP. Stratagene r ports an average mutation rate of 
one mutation per every 2000 nucleotides per colony [20]. While the 
entire plasmid contains 7.65 kb, only mutations made in the 1.41 kb 
heme domain coding region should have an effect on substrate bind- 
ing. Therefore, one could expect o see an average of 3-4 mutations in 
each colony, with only 0-1 mutations per colony in the heme domain 
region. Plasmid DNA was extracted from 91 of the 100 cultures and 
purified by alkaline lysis of the cell pellet [21]. Each purified plasmid 
DNA was then transformed into competent DH5-c~ cells to keep the 
DNA stable and prevent further mutations. 
2.1. Screening the library 
Cell lysate solutions of the random mutants were used for all of the 
screening. These were prepared from 50 ml cell cultures for each 
random mutant. The cell pellets were resuspended in 0.6 ml of lysis 
buffer (50 mM potassium phosphate, pH 8.0, 0.1 mM EDTA, 8 mM 
MgC12 and 2 mM dithiothreitol (DTT)) and lysed by sonication for 
two 30 s periods interspersed by a 1 min incubation on ice. 
Expression levels of P450BM 3 in each colony were determined by 
CO difference spectra [22]. The electronic absorbance spectra were 
obtained with a Hitachi U-3300 spectrometer using a scan rate of 
600 nm/min. 
The library was then screened by comparing CO geminate recombi- 
nation kinetics using flash photolysis. The samples contained enough 
P450BX~ _:~ lysate solution (100-200 Ixl) to give a total optical density 
change of roughly 0.01 in the geminate traces, 200 ~tM sodium lau- 
rate, and dithionite in 0.1 M potassium phosphate buffer (pH 7.4) 
saturated with CO. The CO geminate kinetics for the purified proteins 
were taken with concentrations of 2.5 ~tM P450 and 100 laM palmi- 
tate. 
The laser flash photolysis ystem utilized for these investigations has 
been previously described [12]. Data was taken on the microsecond 
time scale with the monochrometer passband at 450 nm with a 3-4 
nm width. The data was analyzed using Mathmatica (Wolfram Re- 
search). All spectra were normalized to unity by the maximum ob- 
served change in optical density. 
2.2. Prote& purification and character&ation 
The three random P450~3M_3 mutants elected for further screening 
were over expressed in E. coli and purified to homogeneity. Each 
mutant was purified in the same manner as wild type, as previously 
described in the literature [23]. 
The mass spectra of the proteins were obtained at the Mass Spec- 
trometry Laboratory at the University of Illinois, using the electro- 
spray ionization technique with a VG Quattro mass spectrometer. 
DNA sequencing of puc13bm3r82 plasmid DNA was accomplished 
by both dideoxy chain termination method (USB) and fluorescence 
labeling at the University of Illinois Sequencing Facility. 
Product distribution analysis for the fatty acid hydroxylations was 
carried out as previously described [24]. The xanthotoxin metabolism 
assays were carried out as previously described [25] and analyzed by 
HPLC. The reactions used protein concentrations ranging from 0.9 to 
2.5 IxM. The rate of NADPH oxidation was measured by monitoring 
the decrease in absorbance at 340 nm using an extinction coefficient of 
6.22 mM -] cm -1. The reaction consisted of 0.1 M potassium phos- 
phate, pH 8.0, 200/aM substrate and varying amount of protein, and 
was initiated with 150 ~tM NADPH. The oxidation rate was calcu- 
lated from the rate over the first 30 s. 
Substrate binding was measured by spectrophotometric titration of 
protein with substrate at 25°C. The reaction mixture contained l ~2  
IxM enzyme in 0.5 M KPi, pH 8.3. Binding of substrate induced a spin 
state change from low to high spin with Soret band shift from 418 to 
392 nm. The dissociation constant was determined from the slope of 
the plot (AA418+AA392) verses ((AA41s+AA392)/[substrate]). 
2.3. Molecular modeling of P25Q 
Using the crystal structure of wild-type substrate-bound P450BM 3 
[11], the mutation found in random mutant 82 (P25Q) was modeled 
using QUANTA (MSI) molecular graphics and modeling software. 
The residue Pro 25 was replaced with a glutamine and then the protein 
was energy minimized using the CHARMm package with the steepest 
descent method, while constraining the heme atoms. 
Table 1 
Regiospecificity for fatty acid hydroxylation of wild-type (WT) BM3 and P25Q mutant 
Hydroxylated position Laurate (%) Myristate (%) Palmitate (%) 
WT P25Q WT P25Q WT P25Q 
o3-1 35 + 0.7 31.5 + 0.5 44.5 + 2.2 35.0 + 1.6 34 + 1.8 25 + 2.6 
0)-2 29 _+ 0.8 28.5 + 0.6 34.0 + 2.8 27.5 + 1.9 46 + 1.7 50 + 0.8 
(o-3 36+0.7 40.0+0.5 21.5+3.5 37.5+_2.6 20+0.9 25+_2.3 
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Fig. 2. Energy minimized model structure of P450~M :~ with the P25Q mutation replaced in the crystal structure of the palmitoleic bound 
P450n~l :~ [11]. The spatial relation of residues Y51 and R47 to the P25Q mutation are shown, as well as the palmitoleic substrate and the 
heine group. 
3. Results 
The CO difference spectra of the random library show a 
wide range of expression levels for the mutant P450BM :~ pro- 
teins. Although the expression of each mutant varied slightly 
each time it was grown, some mutants consistently expressed 
better than others. One mutant culture showed a small Soret 
peak at 420 nm instead of 450 nm which is characteristic of 
expression of the inactive form of the enzyme, cytochrome 
P420. 
Screening by CO flash photolysis produced three mutants 
with significantly different geminate rates than the wild type. 
Most of the geminate recombination kinetics of the mutants 
were identical to that of wild type within the sensitivity of 
these measurements. Fig. 1 displays the CO geminate transi- 
ents of wild-type and random mutants 44, 74, and 82. These 
three were selected as qualitatively having different transients 
than the wild-type protein. 
Mass spectrometry data was obtained for wild-type and 
random mutants 82 and 74. The mass of mutant 82 
(117685 +20 Da) is consistent with a single point mutation 
when compared to the wild type (117 643 + 26 Da). The mass 
of mutant 74 (56000 Da) suggested a truncation of the pro- 
tein and was therefore excluded from further characteriza- 
tions. The mass of mutant 44 was consistent with that of 
wild type. 
Table 1 presents the data for the relative product distribu- 
tions of the ~-1, w-2 and ~-3 hydroxylation products for 
wild-type and the P25Q mutant (random mutant 82). The 
distributions for random mutant 44 were approximately 
_+ 2% the values of wild type (data not shown). 
The mutants were assayed fbr xanthotoxin metabolism in 
order to assay for changes in the binding pocket which would 
enhance the catalysis of a non-native substrate. The results 
show a decrease in activity for mutant 82 as compared to 
wild type. Although the activity of P450w~l :~ is overall 
much less for xanthotoxin than its natural fatty acid sub- 
strates, it is drastically reduced in mutant 82. The specific 
activity of xanthotoxin for wild-type, mutant 44, and mutant 
82 were 19.2 _+ 0.2, 16.8 + 0.8, and 1.5 + 0.03 fmol Xanthotoxin 
rain ~ pmol P450 -~, respectively. Since both the fatty acid 
product distributions and the xanthotoxin activity for mutant 
44 were similar to wild type, it was excluded from further 
characterization. 
The sequence for random mutant 82 heine domain showed 
only a single mutation of a cytosine to adenine. The resulting 
protein mutation was the change of amino acid number 25 
from a proline to a glutamine. A model of the minimized 
structure of P25Q P450I~M :~ is shown in Fig. 2. This modeled 
structure shows the proximity of the P25Q mutation, residue 
R47, and residue Y51 relative to the substrate and heine. 
The NADPH oxidation rates for P25Q P450t~M :~ and ex- 
perimental dissociation constants are presented in Table 2. 
Typical plots for the determination of dissociation constants 
for wild type and P25Q are shown in Fig. 3. The dissociation 
constants how only a small difference in values for laurate, 
approximately a 5-fold change for the binding of myristate to 
the P25Q mutant, and approximately a 125-fold change in the 
Table 2 
NADPH oxidation rates and substrate dissociation rates for wild-type (WT) and P25Q P450~M :~ 
Substrates NADPH oxidation (nmol/min/nmol P450) 
WT P25Q 
Dissociation constant (gM) 
WT P25Q 
Laurate 893+ 50 434_+ 76 27.20 _+5.0 34.4 _+ 1.0 
Myristate 2461 _+ 156 1558+ 89 2.17 _+0.3 10.9 _+(I.28 
Palmitate 2360 _+ 172 2012 _+ 135 0.021 _+ 0.005 2.87 _+ 0.6 
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Fig. 3. An Eadie-Hofstee like plot for the determination f substrate 
dissociation constants for the wild type and P25Q for three fatty 
acid substrates. (A) laurate, (B) myristate, (C) palmitate. 
binding of palmitate. It should be noted that the values de- 
termined cannot be compared to those previously published 
[26,27], since these experiments were conducted at a higher pH 
(pH 8.3) to increase the solubility of the fatty acids. Also, to 
alleviate the need to reach a saturated endpoint for the deter- 
mination of the concentration of free substrate, an Eadie- 
Hofstee like plot was used, where AA versus zkA/[substrate] 
was plotted. From this plot, the dissociation constant is de- 
termined from the slope and AA .... is extrapolated. This al- 
lows for the determination of dissociation constants without 
having to reach a saturated endpoint. The data was replicated 
several times for each sample and was found to be reproduc- 
ible by this method. 
CO geminate recombination rates were determined for the 
purified P25Q and wild-type proteins. The data was fitted with 
a four-state sequential model, as proposed in previous work 
[12]. The geminate rate constants and yields are given in Table 
3. The kinetics for P25Q appear to be about the same as wild 
type. There is no difference in the geminate yields of substrate- 
bound P25Q and wild type; however, the substrate-free form 
of P25Q has a 5% lower geminate yield than the wild type. 
These results are consistent at both low (100 mM KPi) and 
high (250 mM KPi) salt concentrations. 
4. Discuss ion 
Over the last several years many studies have contributed to 
better understanding the substrate-binding process in P450 
enzymes. The focus has primarily been on using crystal struc- 
tures [11,28], sequence alignments [19,29], and experimental 
data to help predict what changes a particular mutation 
should induce on substrate metabolite profiles. While head- 
way has been made in this area, there are still a lot of ques- 
tions which remain unanswered. In this communication we 
have used random mutagenesis to shed light on important 
residues controlling substrate binding a d metabolism in 
P450BM-3. 
While the methodologies a sociated with random mutagen- 
esis can generate large libraries with a potential spectrum of 
alterations in enzymatic function, the high degeneracy re- 
quires creative solutions to the problems of screening. The 
method of screening successful in this case was the use of 
CO geminate recombination i a similar manner to one pre- 
viously used by Huang and Boxer [30]. CO geminate rebind- 
ing has previously provided substantial information about 
ligand binding and conformational dynamics for various cy- 
tochrome P450s [31-33[. Most recently, a study on CO bind- 
ing in P450BM-3 has provided important information on the 
conformational dynamics of this heine protein [12]. This study 
showed large changes in the recombination kinetic rate con- 
stants between the substrate-bound and substrate-free forms 
of the native protein. Therefore, it was postulated that alter- 
ations in the substrate-binding pocket should be detectable by 
observing changes in the CO recombination kinetics. This 
method afforded the two major advantages of being protein 
concentration i dependent and a sensitive probe of the P450 
active site. 
Screening by CO geminate recombination produced three 
possible candidates which had qualitatively different kinetic 
rates than the wild type. Upon further characterization of
these three random mutants, one mutant P450 was found to 
have drastically different substrate-binding properties. The 
data from mass spectrometry, fatty acid product analysis, 
and xanthotoxin metabolism aided in narrowing down these 
few mutants. The selected mutant, P25Q, had different char- 
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Table 3 
CO geminate rates for wild type and P25Q 
217 
h'o k2 
Fe-CO ~ Fe: :CO 
kl k3 
k k2 k:~ 
(~s l) (las l) (~ts l) 
Substrate free 
WT 9.3 +_ 0.5 40.3 +_ 1.0 1.6 +_ 0.2 
P25Q 8.8___0.4 51.2_+1.0 0.95+_0.09 
Palmitate bound 
WT 20.1 +_ 1.2 25.7 +_ 3.6 3.2 +_ 0.6 
P25Q 20.8+_0.2 30.3_+0.2 3.7 +_0.5 
k4 
Fe: : :CO ~ Fe+ CO 
k5 
kL Gem. yield 
(Its ~) ('! i,) 
4.7 +- 0.2 20 
4.8+-0.6 15 
5.1 _+0.1 53 
6.2+_0.2 52 
acteristics than wild type in all of these assays, again indicat- 
ing a perturbation of the active site. 
Molecular modeling of P25Q P450BM ~, together with the 
help of the recently solved crystal structure for palmiteoleic- 
bound P450BM 3 [11], provided substantial insight as to the 
origin of the altered specificities. The substrate access channel 
is fairly open in the substrate-free crystal form, placing P25 a
significant distance from the substrate. However, in the sub- 
strate-bound crystal form, P25 is directly across from the R47 
and T51 residues which are thought o be involved in forming 
ionic bonds or hydrogen bonding to the carboxyl end of the 
substrate. The modeled structure of the P25Q mutant shows a 
significant steric hindrance of the substrate due to the exten- 
sion of the glutamine side chain. It is also possible that a 
glutamine residue in this position could hydrogen bond to 
the carboxyl group on the substrate, conceivably causing the
substrate to orient differently in the pocket. 
Detailed characterization f the P25Q mutation revealed 
three main effects of the mutation, consistent with the pro- 
posed model. The largest effect was a 100-fold decrease in 
affinity for palmitate. This represents a significant change in 
the active site to accommodate he C-16 fatty acid. The effect 
drastically decreased as the size of the fatty acid decreased. 
This is most likely due to the tighter fit of the longer chain 
fatty acids in the binding pocket as opposed to the 'looser' 
fitting of the shorter chains. Since Arg 47 has been suggested to 
provide interactions necessary for the initial docking of the 
substrate, it follows that a large steric hindrance in close prox- 
imity would greatly decrease the affinity for the substrate, 
especially the tighter fitting substrates. 
The second effect was a change in distribution of the hy- 
droxylation products by P25Q. For the three substrates, the 
trend is a change in preference for hydroxylation from w-1 to 
~-3. These changes in hydroxylation specificity of the enzyme 
can be explained by a different orientation of the substrate in 
the pocket of P25Q The terminal end of the substrate is 
perhaps being oriented in a slightly different position, to ac- 
commodate for the steric hindrance and the possible forma- 
tion of new hydrogen bonds to the glutamine residue at the 
carboxy end of the substrate. 
The third observed effect was alteration of the CO geminate 
recombination kinetics of the purified protein. The P25Q mu- 
tation shows no noticeable effect on the substrate-bound form 
of the protein, but lowers the geminate yield of the substrate- 
free form. If the P25Q mutation is predominately causing a 
steric hindrance in the substrate access channel, it could be 
rationalized as closing the pocket and therefore, having a 
slightly higher geminate yield. However, since in the sub- 
strate-free form it is causing a decrease in geminate yield, 
there is clearly another effect contributing. It is possible that 
the glutamine residue induces changes on the structure of the 
A helix. Residue 25 is the first residue of the A helix of 
P450BM 3, which lies near the top of the substrate access 
channel. If this structure were slightly altered ue to the differ- 
ences of phi-psi angles between proline and glutamine, the 
helix could shift and result in a more open conformation of 
the access channel. Then upon substrate binding, the interac- 
tions between the substrate and protein in this area would 
force the helix back into the 'wild type' orientation, and afford 
CO rebinding kinetics imilar to wild type. 
Results obtained from the steady-state urnover show only 
small differences between wild type and P25Q. Although 
P25Q binds palmitate approximately 100-fold weaker than 
wild type, the maximal velocities of NADPH oxidation were 
approximately the same. Therefore, this residue does not ap- 
pear to play a large role in the catalytic mechanism, rather the 
differences seem to be caused by alterations in substrate rec- 
ognition and orientation. 
In summary, a mutation in the region that is thought o be 
responsible for initial recognition of the fatty acids, has been 
isolated where the affinity of the tightly binding substrates and 
the regioselectivity for hydroxylation is greatly reduced. This 
can be attributed to both steric hindrance and a possible con- 
formation change of the protein in the substrate-free form. 
Through the use of random mutagenesis we were able to 
elucidate an interesting mutation which provides information 
about the initial recognition and docking of substrate, which 
may not have otherwise been found. 
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